Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4213066
Max Phase: Preclinical
Molecular Formula: C92H114N34O16
Molecular Weight: 1952.15
Molecule Type: Unknown
Associated Items:
ID: ALA4213066
Max Phase: Preclinical
Molecular Formula: C92H114N34O16
Molecular Weight: 1952.15
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN(CCCN)CCCNC(=O)CCNC(=O)c1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4cc(NC(=O)CCNC(=O)c5cc(NC(=O)c6cc(NC(=O)CCCNC(=O)c7cc(NC(=O)c8cc(NC(=O)c9cc(NC(=O)CCNC(=O)c%10cc(NC(=O)c%11cc(NC(=O)c%12nc(N=C(N)N)cn%12C)cn%11C)cn%10C)cn9C)cn8C)cn7C)cn6C)cn5C)cn4C)cn3C)cn2C)cn1C
Standard InChI: InChI=1S/C92H114N34O16/c1-114(27-15-21-93)28-16-23-96-75(127)18-24-98-81(132)64-33-57(45-116(64)3)106-88(139)71-38-61(49-123(71)10)110-89(140)72-37-60(48-124(72)11)109-86(137)69-31-54(42-121(69)8)103-77(129)19-25-99-82(133)65-34-56(44-117(65)4)104-84(135)67-29-52(40-119(67)6)101-76(128)17-14-22-97-80(131)63-32-55(43-115(63)2)105-87(138)70-36-59(47-122(70)9)108-85(136)68-30-53(41-120(68)7)102-78(130)20-26-100-83(134)66-35-58(46-118(66)5)107-90(141)73-39-62(50-125(73)12)111-91(142)79-112-74(51-126(79)13)113-92(94)95/h29-51H,14-28,93H2,1-13H3,(H,96,127)(H,97,131)(H,98,132)(H,99,133)(H,100,134)(H,101,128)(H,102,130)(H,103,129)(H,104,135)(H,105,138)(H,106,139)(H,107,141)(H,108,136)(H,109,137)(H,110,140)(H,111,142)(H4,94,95,113)
Standard InChI Key: PTCMHYKAIMIXRM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1952.15 | Molecular Weight (Monoisotopic): 1950.9152 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Castaneda CH, Scuderi MJ, Edwards TG, Harris GD, Dupureur CM, Koeller KJ, Fisher C, Bashkin JK.. (2016) Improved Antiviral Activity of a Polyamide Against High-Risk Human Papillomavirus Via N-Terminal Guanidinium Substitution., 7 (11): [PMID:27840672] [10.1039/C6MD00371K] |
Source(1):